Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
Value $4.99 Backorders typically ship within 5-7 days from order date
486 Clinically, early recognition and differentiation of focal and multifocal neuropathies are crucial for effective management, which includes stringent glycemic control, pain management, and addressing underlying vascular or inflammatory processes
We profile key market players, analyze their strategies, product offerings, and recent developments
Since 2005, a number of them have been approved by the FDA to treat type-2 diabetes, one of the comorbid conditions Warner referred to, such as exenatide, or Byetta
Long-term safety and efficacy data remain limited for both agents, as most clinical trials have been of relatively short duration
